NKTX•benzinga•
Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space
Summary
Nkarta posts a smaller Q1 loss than expected and maintains strong cash reserves while analysts debate its trial strategy and market position.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 15, 2025 by benzinga